UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

PSMA PET Response Guided SabR in High Risk Pca

Phase 1

Recruiting

Conditions: Prostate Adenocarcinoma

Interventions: Drug: 68-Ga PSMA11

First Posted Date: 2023-09-21

Last Posted Date: 2024-03-12

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 20

Registration Number: NCT06044857

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

DIALYSIS-TIR Study

Phase 4

Recruiting

Conditions: End Stage Renal Disease on Dialysis
Type 2 Diabetes

Interventions: Drug: Placebo
Drug: Semaglutide

First Posted Date: 2023-09-18

Last Posted Date: 2024-02-13

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 157

Registration Number: NCT06042153

Locations: 🇺🇸
Davita UT Southwestern - Oak Cliff, Dallas, Texas, United States
🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States
🇺🇸
DaVita UT Southwestern - East Dallas, Dallas, Texas, United States

and more 2 locations

Evaluating Intercostobrachial Nerve Block's Effect on Pain Control After Shoulder Replacement

Not Applicable

Conditions: Shoulder Pain
Postoperative Pain, Acute

Interventions: Procedure: intercostobrachial nerve block

First Posted Date: 2023-09-18

Last Posted Date: 2024-11-05

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 74

Registration Number: NCT06042608

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Pressure Alternating Shoes (PAS) for Prevention of Diabetic Foot Ulcers

Not Applicable

Completed

Conditions: Foot Ulcer, Diabetic

Interventions: Device: test pressure alternating shoes

First Posted Date: 2023-09-07

Last Posted Date: 2024-12-04

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 4

Registration Number: NCT06026813

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder

Not Applicable

Not yet recruiting

Conditions: Spina Bifida

Interventions: Device: Transcutaneous Tibial Nerve Stimulation (TTNS) treatment

First Posted Date: 2023-09-06

Last Posted Date: 2024-12-02

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 12

Registration Number: NCT06025734

EGCG for Hepatocellular Carcinoma Chemoprevention

Phase 2

Recruiting

Conditions: Cirrhosis, Liver

Interventions: Other: Placebo
Drug: Epigallocatechin gallate (EGCG)

First Posted Date: 2023-08-29

Last Posted Date: 2024-11-07

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 60

Registration Number: NCT06015022

Locations: 🇺🇸
UT Southwestern, Dallas, Texas, United States

Studying the Health of Asians to Advance Knowledge, Treatments, and Interventions for Depression

Recruiting

Conditions: Treatment Resistant Depression
Bipolar Disorder
Mental Disorders
Bipolar and Related Disorders
Depression
Mood Disorders

Interventions: Other: Observational Study

First Posted Date: 2023-08-21

Last Posted Date: 2024-08-13

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 6000

Registration Number: NCT06002204

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy

Phase 3

Recruiting

Conditions: Osteoporosis
Hypomagnesemia

Interventions: Drug: EffCaMgCit
Other: Placebo

First Posted Date: 2023-08-21

Last Posted Date: 2024-05-22

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 56

Registration Number: NCT05998863

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones

Phase 4

Recruiting

Conditions: Calcium Phosphate Kidney Stones

Interventions: Dietary Supplement: OHCit- low dose
Drug: Placebo
Dietary Supplement: OHCit- standard dose
Drug: Potassium Citrate

First Posted Date: 2023-08-21

Last Posted Date: 2024-04-12

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 25

Registration Number: NCT06003348

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer

Phase 2

Recruiting

Conditions: Colorectal Cancer

Interventions: Drug: all trans Retinoic Acid
Drug: Atezolizumab
Drug: Bevacizumab

First Posted Date: 2023-08-21

Last Posted Date: 2024-01-19

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 21

Registration Number: NCT05999812

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy